Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115356) titled 'Multi-omics Precision Subtyping and Treatment for Prostate Cancer' on Dec. 25, 2025.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Zhejiang Provincial People's Hospital
Condition:
Prostate cancer, Castration-resistant prostate cancer, Prostate cancer with bone metastasis
Intervention:
Metastatic prostate cancer:None
Localized high-risk prostate cancer:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: Metastatic prostate cancer:100;Localized high-risk prostate cancer:100;Low-risk prostate cancer:100;
Countries o...